Compass Therapeutics, Inc. (NASDAQ:CMPX) Given Consensus Recommendation of “Buy” by Brokerages
Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Free Report) have received an average rating of “Buy” from the nine ratings firms that are currently covering the company, Marketbeat.com reports. Eight analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price […]
Shares of Compass Therapeutics, Inc. (NASDAQ:CMPX – Get Free Report) have received an average rating of “Buy” from the nine ratings firms that are currently covering the company, Marketbeat.com reports. Eight analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price […]
